BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6557687)

  • 1. Granulocyte enzyme mediated degradation of human fibrinogen in plasma in vitro.
    Sterrenberg L; Gravesen M; Haverkate F; Nieuwenhuizen W
    Thromb Res; 1983 Sep; 31(5):719-28. PubMed ID: 6557687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
    Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
    Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
    Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
    J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.
    Sterrenberg L; Haak HL; Brommer EJ; Nieuwenhuizen W
    Haemostasis; 1985; 15(2):126-33. PubMed ID: 3859461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.
    Kohno I; Inuzuka K; Itoh Y; Nakahara K; Eguchi Y; Sugo T; Soe G; Sakata Y; Murayama H; Matsuda M
    Blood; 2000 Mar; 95(5):1721-8. PubMed ID: 10688830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
    Plow EF; Gramse M; Havemann K
    J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen degradation by two neutral granulocyte proteinases. Influence of calcium on the generation of fibrinogen degradation products with anticlotting properties.
    Bingenhkeimer C; Gramse M; Egbring R; Havemann K
    Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):853-63. PubMed ID: 6456216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage and inactivation of Factor IX by granulocyte elastase.
    Takaki A; Enfield DL; Thompson AR
    J Clin Invest; 1983 Nov; 72(5):1706-15. PubMed ID: 6605369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase.
    Feinstein G; Janoff A
    Biochim Biophys Acta; 1975 Oct; 403(2):493-505. PubMed ID: 810168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion.
    Ohlsson M; Rosengren M; Tegner H; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1323-8. PubMed ID: 6195067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and partial characterization of a D-like fragment from human fibrinogen, produced by human leukocyte elastase.
    Sterrenberg L; Nieuwenhuizen W; Hermans J
    Biochim Biophys Acta; 1983 Jan; 755(2):300-6. PubMed ID: 6550499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of granulocyte elastase specific IgG split products in rheumatoid synovial fluid.
    Eckle I; Kolb G; Neurath F; Havemann K
    Adv Exp Med Biol; 1988; 240():531-4. PubMed ID: 3245504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative elastase-mediated degradation of fibrinogen and fibrin observed in a patient with herpes simplex encephalitis and pneumonia.
    Iijima K; Murakami F; Horie Y; Nakamura K; Ikawa S; Soe G; Kohno I; Nakayasu H; Shimomura T; Takahashi K
    Thromb Haemost; 1996 Aug; 76(2):184-6. PubMed ID: 8865527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of elasnin, a new human granulocyte elastase inhibitor produced by a strain of Streptomyces.
    Ohno H; Saheki T; Awaya J; Nakagawa A; Omura S
    J Antibiot (Tokyo); 1978 Nov; 31(11):1116-23. PubMed ID: 721707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinogen split products of neutral proteases from human granulocytes; characterization and effect on in vitro blood coagulation].
    Gramse M; Bingenheimer C; Egbring R; Havemann K
    Verh Dtsch Ges Inn Med; 1978; (84):1353-6. PubMed ID: 741965
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen split products, antiproteases and granulocytic elastase in patients with lung cancer.
    Gropp C; Egbring R; Havemann K
    Eur J Cancer (1965); 1980 May; 16(5):679-85. PubMed ID: 6967016
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and characterization of the elastase-like enzyme of the bovine granulocyte.
    Marossy K; Hauck M; Elödi P
    Biochim Biophys Acta; 1980 Sep; 615(1):237-45. PubMed ID: 6903450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of human granulocyte elastase and kininogenase].
    Platonova LV; Ogloblina OG; Paskhina TS; Martynov VF; Sorochinskaia EI
    Biokhimiia; 1983 Jun; 48(6):1006-11. PubMed ID: 6554073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-plasmin inhibitor inactivation by human granulocyte elastase.
    Gramse M; Egbring R; Havemann K
    Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):19-26. PubMed ID: 6562066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.